Here is a presentation on Korea’s Biotech Industry, which was prepared by Invest KOREA’s High-Tech Industry Investment Promotion Team -
A few points of interest -
- The Korean government’s biotech sector investment amount has been growing at a CAGR of 14.2%, and is expected to increase further, ranking first among government R&D investments in 2009
- Korea is rapidly becoming an aging society –the percentage of Koreans over 65 is expected to reach about 13% by 2015
- CAGR of healthcare expenditure to GDP in Korea is about twice higher (2.98%) than the OECD average(1.62%), and also, the percentage of drug expenditure in total healthcare expenditure (25.8%) is higher than the OECD average (17.6%).
For more information here is a presentation prepared by KOBIOVEN – the Korea Bio Venture Association - Status of Bio-industry in Korea
And here is a detailed report prepared by Invest KOREA – Promising Investment Opportunities – Biotech-Pharmaceutical
If you would like to know more about some Korean biotech companies who are currently inviting investment please contact us through the details shown on the right.

